J&J to acquire Firefly Bio for $1bn to enhance oncology pipeline

Tuesday, June 9, 2026Salong DebbarmaView original

J&J has agreed to buy Firefly Bio for $1bn in cash, aiming to strengthen its oncology pipeline with Firefly Bio’s Firelink DAC platform.

Read the full article on the original site.